H.R. 8440 · 117th Congress

Right to Try Clarification Act

Stage
In committee
Introduced
2022-07-20
Latest action
2022-11-01 · Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Summary

Right to Try Clarification Act

This bill specifies that investigational drugs that are provided directly to individuals from manufacturers without the need for federal regulatory approval (i.e., via the Right to Try pathway) are exempt from restrictions that would otherwise apply under the Controlled Substances Act (e.g., restrictions on the use or possession of schedule I controlled substances).